$179.00 – $274.00
You can buy Mounjaro weight loss pens from our US registered online prescribing service. Mounjaro is the latest GLP-1 weight loss injection available in the US, and is the most effective. It has surpassed the effectiveness of Semaglutide (Ozempic + Wegovy), with an average of 22.5% body weight loss.
You can order Mounjaro after completing an online assessment with our GPs. If a prescription is approved, this is passed to our pharmacy team, who prepare and post your treatment.
Wegovy is from the same family of drugs, and is licensed for weight loss use in the US.
Mounjaro is a highly effective, US licensed weight loss treatment. It has been shown in clinical trials to help achieve up to 23% body weight loss. It is the latest GLP-1 weight loss injection, and is used for people with a body mass index (BMI) over 30. It can also be prescribed for patients with a BMI of 27+ and a weight-related medical condition, such as high blood pressure or cholesterol.
It contains the drug tirzepatide and is a registered trademark of Eli Lilly.
It is known as Zepbound in the US, but launched in the UK under the brand name Mounjaro.
It is used ONCE weekly, as a subcutaneous (under the skin) injection. How Mounjaro Weight Loss Pens Work
Mounjaro weight loss pens mimic the action of GLP-1, a natural hormone produced in the gut. This innovative treatment promotes significant weight loss for patients by acting similarly to GLP-1. It’s two main effects are;
Both actions lead to eating fewer calories, which results in weight loss. Focusing on a reduced-calorie diet can amplify the benefits of Mounjaro.
Mounjaro also aids in preventing excess sugar from being converted into fat, reducing fat storage in the body.
Mounjaro should only be used to help with weight loss if you have already tried and failed to lose weight through exercise and diet alone. Mounjaro is now available in the UK, however there are other GLP-1 drugs which are also available. These include Saxenda, Wegovy and Ozempic.
Mounjaro can be used for patients who have a BMI of over 30, or in patients with a BMI over 27, and other risk factors such as;
To read more about our patients experience with this treatment, you can read some of our patients from product reviews tab.
When using Mounjaro pens to suppress appetite, you can expect to lose around 15-25% of your initial body weight after completing treatment. This is the most effective of all the released GLP-1 medications so far.
These figures have been achieved by patients who have maintained on the highest strength of Mounjaro, which is the 15mg strength.
Patients who maintain at 10mg, lose on average of 21%, while patients who maintain at 15mg, can lose around 22.5%.
The lower strengths of Mounjaro 2.5 and 5mg will not achieve the best results. While some weight loss will be observed, the primary function of these doses is to help your body adjust to the drug without experiencing serious side effects.
| Weeks | Dose | Notes |
|---|---|---|
| 1-4 | 2.5 mg once weekly | Initial dose for titration |
| 5-8 | 5 mg once weekly | Assess tolerance before increase |
| 9-12 | 7.5 mg once weekly | Assess tolerance before increase |
| 13-16 | 10 mg once weekly | Monitor for efficacy and tolerability |
| 17-20 | 12.5 mg once weekly | Further increase based on clinical response |
| 21 onwards | 15 mg once weekly | Maintenance dose if well tolerated |
| Quantity | 10mg – Monthly, 12.5mg – Monthly, 15mg – Monthly, 2.5mg – Monthly, 5mg – Monthly, 7.5mg – Monthly |
|---|
Reviews
There are no reviews yet.